Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Sodium:solute symporter (SSS) | ||||||
| Sodium/glucose cotransporter 2 (SGLT2) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Inhibition (Phlorizin) of SLC5A2 | |||||
| Induced Change | Methyl beta-D-glucopyranoside concentration: decrease (FC = 20) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
| Details | It is reported that inhibition of SLC5A2 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Overexpression of SLC5A2 | |||||
| Induced Change | Methyl beta-D-glucopyranoside concentration: increase (FC = 3) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
| Details | It is reported that overexpression of SLC5A2 leads to the increase of methyl beta-D-glucopyranoside levels compared with control group. | |||||
| Sugar transporter (ST) | ||||||
| HepG2 glucose transporter (SLC2A1) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Mutation (Gly286Asp) of SLC2A1 | |||||
| Induced Change | Methyl beta-D-glucopyranoside concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Hereditary haemolytic anaemia [ICD-11: 3A10] | |||||
| Details | It is reported that mutation (Gly286Asp) of SLC2A1 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Mutation (S290A) of SLC2A1 | |||||
| Induced Change | Methyl beta-D-glucopyranoside concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Hereditary haemolytic anaemia [ICD-11: 3A10] | |||||
| Details | It is reported that mutation (S290A) of SLC2A1 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


